Physician profile
Brian Andrew Quick
NPI 1457888653
$606.91
in general payments reported to CMS, 2019-2025
9 companies · $35.55 in 2025
The $35.55 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.48 · 2020: $14.29 · 2021: $29.47 · 2022: $245 · 2023: $264 · 2025: $35.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $152.71 | 2022 | |
| Merck Sharp & Dohme LLC | $142.87 | 2020-2023 | Zerbaxa, Recarbrio, Dificid |
| Astrazeneca Pharmaceuticals LP | $95.73 | 2022-2023 | Tezspire |
| Inogen, INC. | $65.39 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $52.62 | 2023 | |
| Hologic Sales and Service, LLC | $40.44 | 2021-2025 | Acessa Provu System |
| Novo Nordisk INC | $22.08 | 2025 | Rybelsus, Ozempic |
| Shire North American Group INC | $18.48 | 2019 | |
| Hologic INC | $16.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.